Deals this week: Neusoft Medical Systems Co Ltd, OncoStem Diagnostics Visiomed Group


Chinese medical equipment’s provider Neusoft Medical Systems Co Ltd has signed an agreement to integrate DiA Imaging Analysis Ltd's breakthrough automated software tools into its own ultrasound product range.

The agreement will bring cardiac automated tools to Neusoft’s ultrasound products and provide its customers with quick, accurate and reproducible imaging analysis of the heart.

Based in Israel, DiA Imaging Analysis provides next-generation medical imaging analysis technology.

Indian oncology company OncoStem Diagnostics Pvt Ltd has closed a venture financing round led by Sequoia Capital to raise $6m. The funds will be used for research and development (R&D), improving tests for oral, brain and colon cancer, in addition to automating the tests.

The proceeds will also be used for expanding the company’s presence in India and to introduce the test in new markets.

"The agreement will bring cardiac automated tools to Neusoft’s ultrasound products and provide its customers with quick, accurate and reproducible imaging analysis of the heart."

French company Visiomed Group has raised €1m ($1.18m) in gross proceeds through the private placement of convertible bonds.

L1 Capital Corp subscribed to the bonds offering.

Chinese company Double Medical Technology Inc is planning for an initial public offering (IPO) of shares to be listed on the Shenzhen Stock Exchange.

CITIC Securities Co Ltd is the underwriter for the IPO.